Financials in USD. Standardized financial statements.
A compact view of how Longevity Health Holdings Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue? | $1.91M | $50,318 | $0 | $0 | $0 |
| Revenue Growth? | +3701.4% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $818,051 | $6,357 | $124,788 | $242,556 | $0 |
| Gross Profit? | $1.09M | $43,961 | -$124,788 | -$242,556 | $0 |
| Gross Margin? | +57.2% | +87.4% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $8.20M | $5.04M | $5.09M | $5.27M | $1.94M |
| Operating Income? | -$7.11M | -$5.00M | -$5.22M | -$5.51M | -$467,431 |
| EBITDA? | -$6.64M | -$10.50M | -$15.19M | -$5.06M | -$87,253 |
| Income Before Tax | -$6.87M | -$10.75M | -$16.21M | -$9.05M | -$329,382 |
| Income Tax Expense | $36,262 | -$97,279 | $0 | $0 | $0 |
| Net Income? | -$6.91M | -$10.37M | -$15.45M | -$9.05M | -$6.48M |
| EPS? | $-4.01 | $-0.50 | $-0.74 | $-0.50 | $-0.01 |
| Diluted EPS? | $-4.01 | $-0.50 | $-0.74 | $-0.50 | $-0.01 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality